Skip to main content

Table 1 Clinical profile of asthmatic patients (n = 467)

From: Possible role of EMID2 on nasal polyps pathogenesis in Korean asthma patients

Clinical profile Polyp-positive Polyp-negative P-value
Number of subjects (n) 158 309  
Age [year, mean (range)] 46.24 (17.93-76.86) 47.00 (15.40 - 77.88) 0.56
Sex (n, male/female) 55/103 100/209 0.60
Total smoker (Current Smoker; Ex-Smoker) (%) 27.21 (11.39; 15.82) 27.83 (11.33; 16.50) 0.93
Body mass index (kg/m2) 23.95 ± 3.00 24.53 ± 3.51 0.06
% fall of FEV1 by aspirin provocation 12.22 ± 14.39 6.78 ± 11.46 < 0.0001
Blood eosinophil (%) 6.92 ± 6.23 5.98 ± 6.00 0.12
PC20 methacholine (mg/ml) 5.83 ± 8.87 6.88 ± 8.62 0.23
Total IgE (IU/ml) 298.35 ± 469.67 368.39 ± 654.01 0.19
FEV1 (% predicted) 89.67 ± 15.76 91.79 ± 17.33 0.18
FVC (% predicted) 89.02 ± 12.65 87.68 ± 14.56 0.30
Positive rate of skin test (%) 51.90 57.61 0.24
Positive rate of aspirin intolerance (%) 41.77 15.53 < 0.0001
  1. Values are mean ± SE. BMI, body mass index.